Financial reports
10-Q
2024 Q1
Quarterly report
12 Mar 24
10-K
2023 FY
Annual report
16 Jan 24
10-Q
2023 Q3
Quarterly report
6 Sep 23
10-Q
2023 Q2
Quarterly report
14 Jun 23
10-Q
2023 Q1
Quarterly report
16 Mar 23
10-K
2022 FY
Annual report
4 Jan 23
10-Q
2022 Q3
Quarterly report
9 Sep 22
10-Q
2022 Q2
Quarterly report
10 Jun 22
10-Q
2022 Q1
Quarterly report
11 Mar 22
10-K
2022 FY
Annual report
4 Jan 22
Current reports
8-K
Submission of Matters to a Vote of Security Holders
22 Mar 24
8-K
Regulation FD Disclosure
7 Dec 23
8-K
Anixa Biosciences and Cleveland Clinic Present Positive Data for Phase 1 Study of Breast Cancer Vaccine
17 Apr 23
8-K
Submission of Matters to a Vote of Security Holders
10 Mar 23
8-K
Regulation FD Disclosure
8 Dec 22
8-K
Regulation FD Disclosure
29 Sep 22
8-K
Other Events
17 Aug 22
8-K
Departure of Directors or Certain Officers
15 Apr 22
8-K
Submission of Matters to a Vote of Security Holders
11 Mar 22
8-K
Shareholder Nominations Pursuant to Exchange Act Rule 14a-11
9 Dec 21
Registration and prospectus
S-8
Registration of securities for employees
16 Jan 24
S-8
Registration of securities for employees
4 Jan 23
S-3
Shelf registration
9 Sep 22
S-8
Registration of securities for employees
4 Jan 22
424B5
Prospectus supplement for primary offering
24 Mar 21
FWP
Free writing prospectus
22 Mar 21
FWP
Free writing prospectus
22 Mar 21
424B5
Prospectus supplement for primary offering
22 Mar 21
S-8
Registration of securities for employees
7 Jan 21
424B3
Prospectus supplement
9 Jan 20
Proxies
DEF 14A
Definitive proxy
8 Feb 24
DEF 14A
Definitive proxy
27 Jan 23
DEF 14A
Definitive proxy
28 Jan 22
DEF 14A
Definitive proxy
9 Apr 21
PRE 14A
Preliminary proxy
30 Mar 21
DEFA14A
Additional proxy soliciting materials
20 Jul 20
DEF 14A
Definitive proxy
2 Jul 20
PRE 14A
Preliminary proxy
22 Jun 20
DEF 14A
Definitive proxy
12 Sep 19
DEF 14A
Definitive proxy
17 Aug 18
Other
EFFECT
Notice of effectiveness
20 Sep 22
CORRESP
Correspondence with SEC
15 Sep 22
UPLOAD
Letter from SEC
14 Sep 22
EFFECT
Notice of effectiveness
24 Jun 19
CORRESP
Correspondence with SEC
19 Jun 19
UPLOAD
Letter from SEC
18 Jun 19
CT ORDER
Confidential treatment order
15 Feb 18
EFFECT
Notice of effectiveness
26 Oct 17
CORRESP
Correspondence with SEC
24 Oct 17
UPLOAD
Letter from SEC
23 Oct 17